Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases
Disease area: Interstitial lung diseases, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
M. Lehmann, A. T. Kempa, F. Stanzel, M. Serke (Hemer, Germany). First ever report of histologically proven bronchiolitis obliterans organizing pneumonia after antineoplastic treatment of a malignant pleural mesothelioma with cisplatin and pemetrexed. Eur Respir J 2011; 38: Suppl. 55, 2835

Member's Comments

No comment yet.

Related content which might interest you: The incidence of bronchiolitis obliterans organizing pneumonia syndrome after radiation therapy for breast cancer Source: Eur Respir J 2001; 18: Suppl. 33, 220s Year: 2001 Polychemotherapy experience in pleural mesothelioma with or without pemetrexed Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer Source: Eur Respir J 2003; 21: 552-555 Year: 2003 Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004 Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Second-line chemotherapy in malignant pleural mesothelioma (MPM) Source: Eur Respir J 2002; 20: Suppl. 38, 273s Year: 2002 Multiple and bilateral bronchiolitis obliterans organizing pneumonias following chemotherapy for primitive neuroectodermal tumor Source: Eur Respir J 2005; 26: Suppl. 49, 173s Year: 2005 Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017 Is there any advantage of chemotherapy on survival of patients with diffuse malignant pleural mesothelioma? Source: Eur Respir J 2003; 22: Suppl. 45, 29s Year: 2003 Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions Source: Eur Respir J 2004; 24: 263-266 Year: 2004 Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy Source: Annual Congress 2008 - Therapy of thoracic tumours Year: 2008 Systemic treatment of malignant mesothelioma Source: Eur Respir Mon; 2009: 44: 419–434 Year: 2009 Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy Source: Eur Respir J 2003; 22: Suppl. 45, 61s Year: 2003 Systemic treatment of malignant pleural effusion Source: Annual Congress 2005 - What's new in the pleura Year: 2005 Systemic therapy 1 in malignant pleural mesothelioma: chemotherapy Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 Treatment of chemotherapy induced febrile neutropenia in patients with lung and pleural tumours with ertapenem Source: Eur Respir J 2004; 24: Suppl. 48, 73s Year: 2004 Treatment of malignant pleural mesothelioma with caelyx: few responses but good survival Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004 Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia Source: Eur Respir J 2005; 25: 528-533 Year: 2005 Experience of ozonotherapy in complex chemotherapy of acute nonspecific pleural empyema Source: Annual Congress 2009 - Pleural problems, congenital lesions and novel technical devices Year: 2009 Chronic eosinophilic pneumonia after radiation therapy for breast cancer Source: Eur Respir J 2004; 23: 9-13 Year: 2004